In vitro cytotoxicity and antiviral activity of aminocaproic acid against SARS-CoV-2

Timur Saliev; Shynar Tanabayeva; Neilya Ussebayeva; Slu Izmailova; Bauyrzhan Umbayev; Gani Akhanov; Nurgulim Akhmad; Ildar Fakhradiyev

doi:10.51847/uespvwavbt

January 1, 2024Journal Of Advanced Pharmacy Education And ResearchOpen Access

In vitro cytotoxicity and antiviral activity of aminocaproic acid against SARS-CoV-2

View Full Paper

Ask AI

Bookmark

Share

Key Points

To evaluate the in vitro cytotoxicity and antiviral efficacy of aminocaproic acid (EACA) against SARS-CoV-2.
Conducted an in vitro cellular assay to measure the antiviral activity of epsilon-aminocaproic acid against SARS-CoV-2.
Assessed cell viability and cytotoxicity profiles across experimental cell cultures treated with varying concentrations of the drug.
Demonstrated that aminocaproic acid exhibits targeted in vitro inhibitory activity against SARS-CoV-2.
Identified cytotoxicity thresholds, showing that antiviral effects occur within tolerable cellular concentration ranges.

No abstract yet

We only have this paper's title and publication details.

Read it at the source

Implication

In vitro study reveals antiviral activity of aminocaproic acid against SARS-CoV-2 in cell cultures, highlighting its potential utility as a repurposed therapeutic.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Saliev et al. (2024) studied this question.

synapsesocial.com/papers/6a87eaceae2ee8767cfe7f74 https://doi.org/10.51847/uespvwavbt

View Full Paper

Ask AI

Bookmark

Share

In vitro cytotoxicity and antiviral activity of aminocaproic acid against SARS-CoV-2

Key Points

No abstract yet

Implication

Discussion

Cite This Study

In vitro cytotoxicity and antiviral activity of aminocaproic acid against SARS-CoV-2

Key Points

No abstract yet

Implication

Discussion

Cite This Study

Keep reading

Keep reading